279 related articles for article (PubMed ID: 18208538)
1. The incidence of venous thromboembolism among patients with primary lung cancer.
Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.
Lee YG; Kim I; Lee E; Bang SM; Kang CH; Kim YT; Kim HJ; Wu HG; Kim YW; Kim TM; Lee KW; Lee SH; Kim DW; Heo DS
Thromb Haemost; 2014 Jun; 111(6):1112-20. PubMed ID: 24477503
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
Wang Z; Yan HH; Yang JJ; Wang BC; Chen HJ; Zhou Q; Xu CR; Jiang BY; Wu YL
Support Care Cancer; 2015 Mar; 23(3):635-41. PubMed ID: 25155313
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in uterine cancer.
Rodriguez AO; Gonik AM; Zhou H; Leiserowitz GS; White RH
Int J Gynecol Cancer; 2011 Jul; 21(5):870-6. PubMed ID: 21666485
[TBL] [Abstract][Full Text] [Related]
5. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.
Li R; Hermann G; Baldini E; Chen A; Jackman D; Kozono D; Nguyen P; Nohria A; Powell G; Mak R
Lung Cancer; 2016 Jun; 96():41-7. PubMed ID: 27133748
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.
Khorana AA; Palaia J; Rosenblatt L; Pisupati R; Huang N; Nguyen C; Barron J; Gallagher K; Bond TC
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657815
[TBL] [Abstract][Full Text] [Related]
7. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.
Walker AJ; Baldwin DR; Card TR; Powell HA; Hubbard RB; Grainge MJ
Br J Cancer; 2016 Jun; 115(1):115-21. PubMed ID: 27253177
[TBL] [Abstract][Full Text] [Related]
9. Risk and Timing of Venous Thromboembolism After Surgery for Lung Cancer: A Nationwide Cohort Study.
Mørkved AL; Søgaard M; Skjøth F; Ording AG; Jensen M; Larsen TB; Jakobsen E; Højen AA; Noble S; Meldgaard P; Petersen RH; Christensen TD
Ann Thorac Surg; 2024 Feb; 117(2):289-296. PubMed ID: 37890818
[TBL] [Abstract][Full Text] [Related]
10. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma and venous thromboembolism: influence on mortality.
Mahajan A; Wun T; Chew H; White RH
Thromb Res; 2014 May; 133 Suppl 2():S23-8. PubMed ID: 24862141
[TBL] [Abstract][Full Text] [Related]
12. Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.
Icht O; Leader A; Batat E; Yosef L; Shochat T; Goldstein DA; Dudnik E; Spectre G; Raanani P; Hammerman A; Zer A
Oncologist; 2023 Jun; 28(6):e391-e396. PubMed ID: 37014824
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy.
Kaminuma Y; Tanahashi M; Suzuki E; Yoshii N; Niwa H
Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1156-1162. PubMed ID: 32274676
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
Young K; Paz-Ares L; Thatcher N; Spigel DR; Shahidi J; Soldatenkova V; Grau G; Kurek R; Shepherd FA
Thromb Res; 2018 Jul; 167():50-56. PubMed ID: 29787943
[TBL] [Abstract][Full Text] [Related]
15. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
[TBL] [Abstract][Full Text] [Related]
17. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
18. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
[TBL] [Abstract][Full Text] [Related]
19. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
Hill H; Robinson M; Lu L; Slaughter D; Amin A; Mileham K; Patel JN
Thromb Res; 2021 Dec; 208():71-78. PubMed ID: 34742139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
